Clinical Trials Logo

Hot Flashes clinical trials

View clinical trials related to Hot Flashes.

Filter by:

NCT ID: NCT00061711 Completed - Menopause Clinical Trials

Alternative Therapies for Menopause: A Randomized Trial

Start date: July 2000
Phase: N/A
Study type: Interventional

This randomized, controlled trial will evaluate the efficacy and safety of three alternative approaches utilizing phytoestrogens to treat hot flashes and night sweats in peri- and post-menopausal women. The treatments were chosen because of the scientific evidence supporting a possible benefit, the availability of products with adequate quality control, and their frequency of use in naturopathic medicine. RECRUITMENT FOR THIS STUDY SHOULD END BY AUGUST 1, 2003.

NCT ID: NCT00060320 Completed - Breast Cancer Clinical Trials

Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer

Start date: October 2003
Phase: Phase 3
Study type: Interventional

RATIONALE: The herbal supplement black cohosh may be effective in relieving hot flashes in women. PURPOSE: Randomized phase III trial to determine the effectiveness of black cohosh in relieving hot flashes in women who have breast cancer or who are at risk of developing breast cancer.

NCT ID: NCT00031720 Completed - Breast Cancer Clinical Trials

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Start date: March 2002
Phase: Phase 2
Study type: Interventional

RATIONALE: Soy protein supplement may be effective in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease. PURPOSE: Randomized phase II trial to determine the effectiveness of soy protein supplement in reducing hot flushes in postmenopausal women who are receiving tamoxifen for breast disease such as ductal hyperplasia or breast cancer.

NCT ID: NCT00030914 Completed - Hot Flashes Clinical Trials

Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women

Start date: April 2002
Phase: Phase 3
Study type: Interventional

RATIONALE: Medroxyprogesterone and venlafaxine may be effective in relieving hot flashes. It is not yet known whether venlafaxine is more effective than medroxyprogesterone in relieving hot flashes. PURPOSE: Randomized phase III trial to compare the effectiveness of medroxyprogesterone with that of venlafaxine in treating women who are experiencing hot flashes.

NCT ID: NCT00028574 Completed - Prostate Cancer Clinical Trials

Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer

Start date: December 2001
Phase: Phase 3
Study type: Interventional

RATIONALE: Gabapentin may be effective in relieving hot flashes in men who have prostate cancer. It is not yet known which regimen of gabapentin is most effective in treating hot flashes. PURPOSE: Randomized phase III trial to compare different regimens of gabapentin in treating men who have prostate cancer.

NCT ID: NCT00026286 Completed - Breast Cancer Clinical Trials

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

Start date: November 28, 2000
Phase: Phase 3
Study type: Interventional

RATIONALE: Hormone replacement therapy may be effective in managing the hot flashes and/or vaginal symptoms in postmenopausal women who are receiving tamoxifen for breast cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of hormone replacement therapy in managing hot flashes and/or vaginal symptoms in postmenopausal women who are receiving tamoxifen for breast cancer.

NCT ID: NCT00022074 Completed - Breast Cancer Clinical Trials

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Start date: July 2001
Phase: N/A
Study type: Interventional

RATIONALE: Gabapentin may be effective for the control of hot flashes. It is not yet known if gabapentin is effective in treating hot flashes. PURPOSE: Randomized clinical trial to study the effectiveness of gabapentin in controlling hot flashes in women who have breast cancer.

NCT ID: NCT00020865 Active, not recruiting - Lymphoma Clinical Trials

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Start date: September 2001
Phase: Phase 3
Study type: Interventional

RATIONALE: Levofloxacin may be effective in reducing fever and controlling other symptoms of neutropenia in patients who are being treated for cancer. It is not yet known whether levofloxacin is more effective than cefepime in reducing fever and controlling symptoms of neutropenia. PURPOSE: Randomized phase III trial to compare the effectiveness of levofloxacin with that of cefepime in reducing fever and controlling symptoms of neutropenia in patients who are being treated for cancer.

NCT ID: NCT00020527 Completed - Lymphoma Clinical Trials

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Start date: March 2001
Phase: N/A
Study type: Interventional

RATIONALE: Giving caspofungin acetate may be effective in preventing or controlling fever and neutropenia caused by chemotherapy or bone marrow transplantation. PURPOSE: Clinical trial to study the effectiveness of caspofungin acetate in treating children who have fever and neutropenia caused by a weakened immune system.

NCT ID: NCT00010712 Completed - Hot Flashes Clinical Trials

Effects of Black Cohosh on Menopausal Hot Flashes

Start date: September 1999
Phase: Phase 2
Study type: Interventional

This study will assess whether treatment with black cohosh is effective in reducing the frequency and intensity of menopausal hot flashes. In addition, this study will determine whether or not black cohosh reduces the frequency of other menopausal symptoms and improves quality of life.